Gradient Investments Boosts Stake in Alexandria Real Estate Equities

Institutional investor increases holdings in real estate investment trust by over 1,400%

Mar. 24, 2026 at 10:07am

Got story updates? Submit your updates here. ›

Gradient Investments LLC significantly increased its stake in Alexandria Real Estate Equities, Inc. (NYSE:ARE) during the fourth quarter, according to a recent SEC filing. The firm now owns 257,838 shares of the real estate investment trust's stock, up from just 16,593 shares previously, representing a 1,453.9% increase in its holdings.

Why it matters

Alexandria Real Estate Equities is a leading owner, developer, and manager of collaborative life science and technology campuses, with a diversified portfolio across North America and Europe. Gradient Investments' substantial increase in its position suggests the firm sees significant upside potential in the REIT's stock.

The details

Gradient Investments acquired an additional 241,245 shares of Alexandria Real Estate Equities during the fourth quarter, bringing its total position to 257,838 shares. This represents approximately 0.15% of the REIT's outstanding shares. The firm cited the REIT's strong market position and growth prospects as reasons for the increased investment.

  • Gradient Investments filed its most recent 13F report with the SEC on March 24, 2026, disclosing the increased stake in Alexandria Real Estate Equities.

The players

Gradient Investments LLC

An investment management firm that provides portfolio management services to institutional and individual clients.

Alexandria Real Estate Equities, Inc.

A real estate investment trust that specializes in the ownership, development, and management of collaborative life science and technology campuses.

Got photos? Submit your photos here. ›

The takeaway

Gradient Investments' substantial increase in its position in Alexandria Real Estate Equities suggests the firm sees significant long-term potential in the REIT's business model and growth prospects. This move highlights the continued investor interest in the life science and technology real estate sector.